BRWA
EBS icon

B. Riley Wealth Advisors’s Emergent Biosolutions EBS Stock Holding History

B. Riley Wealth Advisors’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-100,000
Closed -$8.82K – 1067
2025
Q3 		$8.82K Buy
+100,000
New +$778K ﹤0.01% 1060

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

B. Riley Wealth Advisors's EBS Position: Q1 2026 in Review

B. Riley Wealth Advisors sold out of Emergent Biosolutions (EBS) in Q1 2026, closing a stake of 10,500 shares — an estimated $130K sold.

B. Riley Wealth Advisors first reported a position in EBS in Q4 2015 and held it in 6 quarters. The position peaked at $400K in Q4 2024. 190 funds tracked by Wall St. Rank hold EBS as of Q1 2026.

  • B. Riley Wealth Advisors reported no remaining Emergent Biosolutions position as of Q1 2026 after selling out during the quarter.
  • B. Riley Wealth Advisors sold 10,500 Emergent Biosolutions shares in Q1 2026, an estimated $130K.
  • B. Riley Wealth Advisors first reported a position in Emergent Biosolutions in Q4 2015 and held it in 6 quarters.
  • B. Riley Wealth Advisors's Emergent Biosolutions position peaked at $400K in Q4 2024.
  • 190 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q1 2026.

Based on B. Riley Wealth Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.